COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia

Cancer Detection and Prevention

Volumn 32, Issue 2, 2008, Pages 135-139

  Dawsey, Sonja P ^a   Roth, Mark J ^a   Adams, Lisa ^a   Hu, Nan ^a   Wang, Quan Hong ^b   Taylor, Philip R ^a   Woodson, Karen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANXI CANCER HOSPITAL   (China)

Author keywords

Cancer; Cyclooxgenase 2; Esophagus; Lymphocytes; Methylation; Neoplasms; Precancerous conditions; Squamous cell cancer

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CELL AGGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LYMPHOCYTE; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SQUAMOUS EPITHELIUM; STROMA CELL;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DNA METHYLATION; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHOCYTES; MICRODISSECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 47749106026     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.05.001     Document Type: Article

References (23)

1. Kim J.B., Stein R., and O'Hare M.J. Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol 26 (2005) 173-185
2. Shekhar M.P., Werdell J., Santner S.J., Pauley R.J., and Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61 (2001) 1320-1326
3. Schor S.L. Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog Growth Fator Res 5 (1994) 223-248
4. Sharma R.A., and Browning M.J. Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?. Crit Rev Oncol Hematol 56 (2005) 5-22
5. Yang L., Parkin D.M., Li L.D., Chen Y.D., and Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90 (2004) 2157-2166
6. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 102 (2002) 271-274
7. Rashid A., and Issa J.P. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 127 (2004) 1578-1588
8. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 3 (2003) 253-266
9. Kikuchi T., Itoh F., Toyota M., Suzuki H., Yamamoto H., Fujita M., et al. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer 97 (2002) 272-277
10. Elder D.J., Halton D.E., Crew T.E., and Paraskeva C. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 86 (2000) 553-560
11. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., and DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58 (1998) 362-366
12. Dawsey S.M., Lewin K.J., Liu F.S., Wang G.Q., and Shen Q. Esophageal morphology from Linxian China. Squamous histologic findings in 754 patients. Cancer 73 (1994) 2027-2037
13. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., et al. Laser capture microdissection. Science 274 (1996) 998-1001
14. Woodson K., Hayes R., Wideroff L., Villaruz L., and Tangrea J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 55 (2003) 199-205
15. Woodson K., Gillespie J., Hanson J., Emmert-Buck M., Phillips J.M., Linehan W.M., et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 60 (2004) 25-31
16. Colella S., Shen L., Baggerly K.A., Issa J.P., and Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 35 (2003) 146-150
17. Tost J., Dunker J., and Gut I.G. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. Biotechniques 35 (2003) 152-156
18. Kekeeva T.V., Popova O.P., Shegai P.V., Alekseev B.I., Adnreeva I., Zaletaev D.V., et al. Abberant methylation of p16, HIC1 N33 and GSTP1 genes in tumor epitelium and tumor-associated stromal cells of prostate cancer. Mol Biol (Mosk) 41 (2001) 79-85
19. Rodriguez-Canales J., Hanson J.C., Tangrea M.A., Erickson H.S., Albert P.S., Wallis B.S., et al. Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol 211 (2007) 410-419
20. Weinberg J.B. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunol Res 22 (2000) 319-341
21. DeLong P., Tanaka T., Kruklitis R., Henry A.C., Kapoor V., Kaiser L.R., et al. Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res 63 (2003) 7845-7852
22. Sharma S., Stolina M., Yang S.C., Baratelli F., Lin J.F., Atianzar K., et al. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res 9 (2003) 961-968
23. Ohno S., Ohno Y., Suzuki N., Inagawa H., Kohchi C., Soma G., et al. Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res 25 (2005) 3679-3687